[1]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295-299.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
　Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(05):295-299.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
点击复制

尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年05期
页码:
295-299
栏目:
论著
出版日期:
2014-10-31

文章信息/Info

Title:
The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease
作者:
高瑞霄; 姚朱华; 冯凭; 唐亮
300350 天津市海河医院内科(高瑞霄),骨科(唐亮); 300121 天津市人民医院心内科(姚朱华); 300052 天津医科大学总医院代谢病科(冯凭)
Author(s):
Gao Ruixiao*; Yao Zhuhua; Feng Ping;  Tang Liang.
*Department of Internal Medicine,Tianjin HaiHe Hospital,Tianjin 300350, China Corresponding author:Yao Zhuhua, Email: tjyzhpci@163.com
关键词:
8-羟基脱氧鸟苷;  糖尿病;  冠心病;  动脉粥样硬化;  氧化应激
Keywords:
8-Hydroxy-2'-deoxyguanosine;  Diabetes mellitus;  Coronary heart disease;  Atherosclerosis;  Oxidative stress
DOI:
10.3760/cma.j.issn.1673-4157.2014.05.002
摘要:
目的 观察糖尿病患者及糖尿病合并冠心病患者尿8-羟基脱氧鸟苷(8-OHdG)水平。方法 来自天津医科大学总医院住院患者及健康查体中心体检人群150名,分为糖尿病组(50例,其中男性25例,女性25例),糖尿病合并冠心病组(50例,其中男性25例,女性25例),正常对照组(50名,其中男性25名,女性25名)。收集24 h尿,通过竞争酶联免疫吸附法定量检测尿液中8-OHdG含量,苦味酸法测定尿肌酐浓度,采用酶法测定血脂、血糖、肾功能,高效液相法测定糖化血红蛋白(HbA1c),Clauss法测定纤维蛋白原(FIB)。结果 与正常对照组[(6.97±2.13)ng/mgCr]相比,糖尿病组[(12.26±3.57)ng/mgCr]及糖尿病合并冠心病组[(14.41±2.84)ng/mgCr]尿8-OHdG水平较高,同时糖尿病合并冠心病组显著高于糖尿病组(P均>0.05)。糖尿病及糖尿病合并冠心病组收缩压、腰围、体重指数、HbA1c、空腹血糖、负荷后2 h血糖、甘油三酯、FIB水平显著高于正常对照组(P均<0.01),高密度脂蛋白-胆固醇水平低于正常对照组(P<0.05); 糖尿病合并冠心病组HbA1c、负荷后2 h血糖、FIB水平显著高于糖尿病组(P均<0.01); 尿8-OHdG水平与收缩压、腰围、体重指数、甘油三酯 、FIB、HbA1c、空腹血糖、负荷后2 h血糖呈正相关; 经多元逐步回归分析,HbA1c对尿8-OHdG水平有显著性影响(P<0.001)。结论 糖尿病及合并冠心病患者尿8-OHdG水平升高; 尿8-OHdG可能成为评价糖尿病性动脉粥样硬化程度的新指标。
Abstract:
Objective To study the level of urinary 8-hydroxy deoxyguanosine(8-OHdG)in type 2 diabetic patients with or without coronary heart disease. Methods 150 cases were selected from hospitalized patients and the physical examination center in the General Hospital of Tianjin Medical University and were divided into diabetic group(n=50, male 25, female 25), diabetic patients with coronary heart disease group(n=50, male 25, female 25)and healthy control group(n=50, male 25, female 25). 24 hours urine were collected, then urinary 8-OHdG was tested with enzyme linked immunosorbent assay, and urine creatinine was tested with trinitrophenol method. Blood glucose, creatinine, uric acid and blood urea nitrogen with enzymatic method, and HbA1c with HPLC method, and fibrinogen(FIB)with Clauss method were also tested. Results Compared with normal control group[(6.97±2.13)ng/mgCr], urinary 8-OHdG was increased in diabetes group[(12.26±3.57)ng/mgCr] and diabetic coronary heart disease group[(14.41±2.84)ng/mgCr].While compared with diabetes group, urinary 8-OHdG was significantly elevated in diabetic coronary heart disease group. Compared with healthy control group, the level of systolic blood pressure, body mass index, HbA1c, fasting blood glucose, 2 hour postprandial blood glucose, triglyceride and fibrinogen were significantly higher in diabetic group and diabetic coronary heart disease group(all P<0.01), and the level of high density lipoprotein -cholesterol was lower(P<0.05). Compared with diabetes group, the level of HbA1c, 2 h postprandial blood glucose and fibrinogen were significantly higher in diabetic coronary heart disease group(all P<0.01). Urinary 8-OHdG was positively related to systolic blood pressure, waist circumference, body mass index, triglyceride, fibrinogen, HbA1c, fasting plasma glucose and 2 h postprandial blood glucose. After stepwise regressive analysis, HbA1c had significant effect on the levels of urinary 8-OHdG(P<0.001). Conclusions The level of urinary 8-OHdG is increased in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease. Urinary 8-OHdG might be a new marker for evaluating diabetic atherosclerosis.

参考文献/References:

[1] 卢雪玲,谢自敬,王宁,等. 2型糖尿病患者动脉粥样硬化若干危险因素分析[J].中国动脉硬化杂志, 2006,14(5):426-429.
[2] 任忠法,薛现中,官庆波. 2型糖尿病患者抗动脉粥样硬化的临床研究进展[J].医学综述, 2009,15(11):1696-1698.
[3] 高瑞霄,姚朱华,邵红霞. 尿8-OHdG与糖尿病性动脉粥样硬化相关性的研究进展[J].天津医药, 2009,37(9):809-811.
[4] Xiang F, Shuanglun X, Jingfeng W, et al. Association of serum 8-hydroxy-2'-deoxyguanosine levels with the presence and severity of coronary artery disease[J].Coron Artery Dis, 2011,22(4):223-227.
[5] 胡仁明,赵咏桔,宋怀东,等. 内分泌代谢病临床新技术[M].北京:人民军医出版社, 2002:451-461.
[6] 鲁燕,陆轶群,李红霞.2型糖尿病患者血清8-羟基脱氧鸟苷酸水平与大血管病变的相关性[J]. 苏州大学学报,2007,27(5):736-738.
[7] Kaya Y, Çeb1 A, Söylemez N,et al.Correlations between oxidative DNA damage, oxidative stress and coenzyme Q10 in patients with coronary artery disease[J]. Int J Med Sci, 2012,9(8):621-626.
[8] Rana JS, Visser ME, Arsenault BJ, et al. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study[J].Int J Cardiol, 2010,143(3):399-404.
[9] 陈燕铭,熊肇军,尹琼丽,等. 2型糖尿病患者血清炎症因子和脂联素水平与动脉粥样硬化的关系[J].中国动脉硬化杂志, 2011,19(10):842-846.
[10] Expert Panel on Detection, Evaluation, an d Treatment of High Blood Cholesterol in Adults1 Executive Summary of The Third Report of the National Cholesterol Education Program(NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅲ)[J].JAMA, 2001,285(19):2486-2497.
[11] Kono K, Fujii H, Nakai K, et al. Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats[J].Am J Nephrol, 2013,37(2):167-174.
[12] Abu-Lebdeh HS, Hodge DO, Nguyen TT. Predictors of macrovascular disease in patients with type 2 diabetes mellitus[J].Mayo Clin Proc, 2001,76(7):707-712.
[13] Schmidt R, Launer LJ, Nilsson LG, et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia(CASCADE)Study[J].Diabetes, 2004,53(3):687-692.
[14] Ravipati G, Aronow WS, Ahn C, et al. Association of hemoglobin A(1c)level with the severity of coronary artery disease in patients with diabetes mellitus[J].Am J Cardiol, 2006,97(7):968-969.
[15] Letonja MS, Nikolajevi-Star evi J, Batista DC, et al. Association of the C242T polymorphism in the NADPH oxidase p22 phox gene with carotid atherosclerosis in Slovenian patients with type 2 diabetes[J].Mol Biol Rep, 2012,39(12):10121-10130.
[16] Abe M, Maruyama N, Suzuki H, et al. Additive renoprotective effects of aliskiren on angiotensin receptor blocker and Calcium Channel blocker treatments for type 2 diabetic patients with albuminuria[J].Hypertens Res, 2012,35(8):874-881.
[17] 黄通,赵丹,陈忠伟,等. 2型糖尿病人群DNA氧化损伤情况分析[J].临床和实验医学杂志, 2008,7(6):5-7.
[18] Lazalde-Ramos BP, Zamora-Perez AL, Sosa-Macías M, et al. DNA and oxidative damages decrease after ingestion of folic acid in patients with type 2 diabetes[J].Arch Med Res, 2012,43(6):476-481.
[19] Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes[J].Diabetes Care, 2003,26(5):1507-1512.
[20] Kim JY, Lee JW, Youn YJ, et al. Urinary levels of 8-iso-prostaglandin f2α and 8-hydroxydeoxyguanine as markers of oxidative stress in patients with coronary artery disease[J].Korean Circ J, 2012,42(9):614-617.

相似文献/References:

[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
　Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(05):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
　Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制 ——2014年美国糖尿病协会“杰出科学成就奖” 演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
　Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[4]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
　Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[5]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
　Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[6]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
　Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[7]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
　Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[8]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
　Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[9]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
　Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
[10]陈金安 柳岚 蒋克春 王爱萍.糖尿病足溃疡中趋化因子的作用及机制[J].国际内分泌代谢杂志,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]
　Chen Jinan,Liu Lan,Jiang Kechun,et al.Roles of chemokines in diabetic foot ulcer and the mechanisms[J].International Journal of Endocrinology and Metabolism,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]

备注/Memo

备注/Memo:
通信作者:姚朱华,Email:tjyzhpci@163.com
更新日期/Last Update: 2014-09-20